Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder

ClinicalTrials.gov ID: NCT07220460

Public ClinicalTrials.gov record NCT07220460. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Sep 11, 2026, 10:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multicenter, Open-label Study to Evaluate the Long-term Safety and Tolerability of ABBV-932 in Subjects With Depressive Episodes Associated With Bipolar I or II Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Bipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population in the United States. The purpose of this study is to assess how safe and effective ABBV-932 is in treating participants with depressive episodes associated with bipolar I or II disorder. ABBV-932 is an investigational drug being developed for the treatment of depressive episodes in adult participants with bipolar I or II disorder. Participants with bipolar I or II disorder who are currently experiencing a depressive episode will enter the study and be treated with open-label ABBV-932. Approximately 200 adult participants with bipolar I or II disorder will be enrolled in approximately 50 sites in the United States and Puerto Rico. Participants will receive oral capsules of ABBV-932 for a 26-week treatment period. The treatment period will be followed by a safety follow-up (SFU) period of 30 days. There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regularly scheduled visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.

Study identification

NCT ID
NCT07220460
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
AbbVie
Industry
Enrollment
200 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 29, 2025
Primary completion
Mar 31, 2027
Completion
Mar 31, 2027
Last update posted
Jun 17, 2026

2025 – 2027

United States locations

U.S. sites
47
U.S. states
22
U.S. cities
43
Facility City State ZIP Site status
Ima Clinical Research Phoenix (Alea) /ID# 278047 Phoenix Arizona 85012 Recruiting
Advanced Research Center /ID# 273474 Anaheim California 92805 Recruiting
Axiom Research /ID# 273482 Colton California 92324 Recruiting
Collaborative Neuroscience Research - Garden Grove /ID# 273492 Garden Grove California 92845 Recruiting
Sun Valley Research Center /ID# 273472 Imperial California 92251 Recruiting
Synergy San Diego /ID# 278340 Lemon Grove California 91945 Recruiting
Alliance for Research Alliance for Wellness /ID# 273477 Long Beach California 90807 Recruiting
Nrc Research Institute - Los Angeles /ID# 278450 Los Angeles California 90015 Recruiting
Excell Research /ID# 273483 Oceanside California 92056 Recruiting
Inland Psychiatric Medical Group /ID# 273471 Temecula California 92591 Recruiting
Sunwise Clinical Research /ID# 278165 Walnut Creek California 94596 Recruiting
Connecticut Clinical Research - Cromwell /ID# 278116 Cromwell Connecticut 06416 Recruiting
Clinical Neuroscience Solutions Healthcare - Jacksonville /ID# 278332 Jacksonville Florida 32256 Recruiting
GMI Florida - Central Miami Medical Institute /ID# 273486 Miami Florida 33125 Recruiting
Allied Biomedical Res Inst Inc /ID# 273476 Miami Florida 33155 Recruiting
Floridian Clinical Research - Miami Lakes /ID# 279379 Miami Lakes Florida 33016 Recruiting
K2 Medical Research - Orlando - South Orlando Avenue /ID# 273487 Orlando Florida 32751 Recruiting
Apg Research /ID# 278439 Orlando Florida 32803 Recruiting
Segal Trials - West Broward Outpatient Research Site /ID# 273496 Tamarac Florida 33319-4985 Recruiting
Health Synergy Clinical Research /ID# 279384 West Palm Beach Florida 33407 Recruiting
Trialmed /ID# 278046 Atlanta Georgia 30328 Recruiting
Atlanta Center for Medical Research /ID# 278827 Atlanta Georgia 30331 Recruiting
Revive Research Institute - Elgin /ID# 279756 Elgin Illinois 60123 Recruiting
Benchmark Research /ID# 273490 Shreveport Louisiana 71101 Completed
Pharmasite Research, Inc. /ID# 279163 Baltimore Maryland 21208 Recruiting
Elixia - Springfield /ID# 278446 Springfield Massachusetts 01103 Recruiting
MSB Neuroscience /ID# 278168 Jackson Mississippi 39216-4643 Recruiting
Arch Clinical Trials /ID# 273481 St Louis Missouri 63125 Recruiting
Alivation Research /ID# 279464 Lincoln Nebraska 68526 Recruiting
Ima Clinical Research Las Vegas (SMO/Network/Consortium) /ID# 278054 Las Vegas Nevada 89102 Recruiting
Redbird Research /ID# 279475 Las Vegas Nevada 89119 Recruiting
Bio Behavioral Health /ID# 273478 Toms River New Jersey 08755 Recruiting
Integrative Clinical Trials /ID# 278040 Brooklyn New York 11229 Recruiting
Neurobehavioral Research /ID# 273470 Cedarhurst New York 11516 Recruiting
Ima Clinical Research - Manhattan /ID# 278941 New York New York 10036 Recruiting
New Hope Clinical Research - Inpatient unit /ID# 273468 Charlotte North Carolina 28211 Recruiting
Quest Therapeutics of Avon Lake /ID# 273484 Avon Lake Ohio 44012 Recruiting
OSU Psychiatry Department /ID# 273495 Columbus Ohio 43210 Recruiting
Sooner Clinical Research /ID# 273491 Oklahoma City Oklahoma 73116 Recruiting
Summit Research Network - Portland - Northwest Vaughn Street /ID# 278084 Portland Oregon 97210 Recruiting
Lehigh Center for Clinical Research /ID# 273466 Allentown Pennsylvania 18103 Recruiting
FutureSearch Trials of Dallas /ID# 273473 Dallas Texas 75231 Recruiting
Epic Medical Research - DeSoto /ID# 278045 DeSoto Texas 75115 Recruiting
Perceptive Pharma Research /ID# 273485 Richmond Texas 77407 Recruiting
Family Psychiatry Of The Woodlands /ID# 278050 The Woodlands Texas 77381 Recruiting
Northwest Clinical Research Center /ID# 273480 Bellevue Washington 98007 Recruiting
Core Clinical Research /ID# 273498 Everett Washington 98201 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07220460, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 17, 2026 · Synced Sep 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07220460 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →